InvestorsHub Logo

gestalt2

05/11/17 2:15 PM

#14538 RE: BlueHorseshoe13 #14537

this is what i got out of that article - as i think everyone did -

"Gilead plans to turn its HIV focus toward longer-acting formulations. Much like it helped decrease the number of pills an HIV patient must take to one a day, Young said, Gilead could zero in on injections that would need to be taken monthly, quarterly or even longer between shots.
"It's more convenient than a daily pill,"

Hmm, i wonder what HIV treatment that is injected and has long term effectivness?

Wonder what the tipping point will be for GILD to do the deal with CYDY? It is obvious what is going on and its all good.

misiu143

05/11/17 2:25 PM

#14539 RE: BlueHorseshoe13 #14537

Very good information , thank you. One thing only ,ok patients will swallow less tablets every day , but side effects are almost the same. Very severe. Read side effects of Truvada.
I am really surprise that so far no BO from Gilead here !!